1. Home
  2. NMRA vs LNKB Comparison

NMRA vs LNKB Comparison

Compare NMRA & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • LNKB
  • Stock Information
  • Founded
  • NMRA 2019
  • LNKB 2018
  • Country
  • NMRA United States
  • LNKB United States
  • Employees
  • NMRA N/A
  • LNKB N/A
  • Industry
  • NMRA
  • LNKB
  • Sector
  • NMRA
  • LNKB
  • Exchange
  • NMRA Nasdaq
  • LNKB Nasdaq
  • Market Cap
  • NMRA 121.0M
  • LNKB 256.4M
  • IPO Year
  • NMRA 2023
  • LNKB N/A
  • Fundamental
  • Price
  • NMRA $0.77
  • LNKB $7.48
  • Analyst Decision
  • NMRA Buy
  • LNKB Strong Buy
  • Analyst Count
  • NMRA 8
  • LNKB 1
  • Target Price
  • NMRA $9.29
  • LNKB $9.00
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • LNKB 62.6K
  • Earning Date
  • NMRA 08-05-2025
  • LNKB 07-28-2025
  • Dividend Yield
  • NMRA N/A
  • LNKB 4.11%
  • EPS Growth
  • NMRA N/A
  • LNKB N/A
  • EPS
  • NMRA N/A
  • LNKB 0.97
  • Revenue
  • NMRA N/A
  • LNKB $120,786,000.00
  • Revenue This Year
  • NMRA N/A
  • LNKB $21.23
  • Revenue Next Year
  • NMRA N/A
  • LNKB N/A
  • P/E Ratio
  • NMRA N/A
  • LNKB $7.54
  • Revenue Growth
  • NMRA N/A
  • LNKB 135.60
  • 52 Week Low
  • NMRA $0.61
  • LNKB $6.00
  • 52 Week High
  • NMRA $17.19
  • LNKB $7.98
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 48.68
  • LNKB 58.73
  • Support Level
  • NMRA $0.75
  • LNKB $6.67
  • Resistance Level
  • NMRA $0.85
  • LNKB $7.09
  • Average True Range (ATR)
  • NMRA 0.11
  • LNKB 0.21
  • MACD
  • NMRA -0.01
  • LNKB 0.02
  • Stochastic Oscillator
  • NMRA 9.14
  • LNKB 97.06

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.

Share on Social Networks: